InvestorsHub Logo
Followers 26
Posts 2588
Boards Moderated 0
Alias Born 10/23/2003

Re: vinmantoo post# 2282

Wednesday, 08/03/2022 8:49:54 AM

Wednesday, August 03, 2022 8:49:54 AM

Post# of 3013
Was the risk any different for their RSV drug?

respiratory syncytial virus did not meet the primary endpoint in a Phase 2b clinical trial. The therapy did not reduce symptoms when compared to placebo;

Appreciate the input??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News